| Dr Luis William Dominguez, MD, MPH | |
|
2150 Pennsylvania Ave, Gw Medical Faculty Associates, Dept Of Emerg. Med., Washington Dc, DC 20037 | |
| (202) 798-0100 | |
| (202) 379-3570 |
| Full Name | Dr Luis William Dominguez |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 9 Years |
| Location | 2150 Pennsylvania Ave, Washington Dc, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083080535 | NPI | - | NPPES |
| MD046182 | Other | DC | LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD046182 (District Of Columbia) | Secondary |
| 207R00000X | Internal Medicine | D0085304 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| United Medical Center | Washington, DC | Hospital |
| George Washington Univ Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| George Washington University Medical Faculty Associates | 4082528898 | 651 |
News Archive
Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.
MicroConstants, a GLP-compliant Contract Research Organization specializing in bioanalytical and pharmacokinetic analysis, has acquired access to a new nanosizing technology that transforms water insoluble compounds into nanoparticles, making formulation preparation and dosing for toxicology studies easier.
A University of Leicester-led study may have uncovered the reason why Beta-blockers are less effective at preventing stroke in older people with high blood pressure, when compared to other drugs for high blood pressure.
ACCESS PHARMACEUTICALS, INC., an emerging biopharmaceutical company, today announced that it had entered into an exclusive license agreement with Norgine B.V., a leading independent European specialty pharmaceutical company, for the commercialization of MuGard in Europe.
In a new trial, Swedish researchers will investigate if a medicine normally used to treat prostate cancer can also be used to treat COVID-19 in patients.
› Verified 6 days ago
| Entity Name | Medical Faculty Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.
MicroConstants, a GLP-compliant Contract Research Organization specializing in bioanalytical and pharmacokinetic analysis, has acquired access to a new nanosizing technology that transforms water insoluble compounds into nanoparticles, making formulation preparation and dosing for toxicology studies easier.
A University of Leicester-led study may have uncovered the reason why Beta-blockers are less effective at preventing stroke in older people with high blood pressure, when compared to other drugs for high blood pressure.
ACCESS PHARMACEUTICALS, INC., an emerging biopharmaceutical company, today announced that it had entered into an exclusive license agreement with Norgine B.V., a leading independent European specialty pharmaceutical company, for the commercialization of MuGard in Europe.
In a new trial, Swedish researchers will investigate if a medicine normally used to treat prostate cancer can also be used to treat COVID-19 in patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Luis William Dominguez, MD, MPH 2150 Pennsylvania Ave Nw, Gw Mfa Department Of Emergency Medicine, Washington Dc, DC 20037 Ph: (202) 798-0100 | Dr Luis William Dominguez, MD, MPH 2150 Pennsylvania Ave, Gw Medical Faculty Associates, Dept Of Emerg. Med., Washington Dc, DC 20037 Ph: (202) 798-0100 |
News Archive
Shire plc today announced it has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration for its investigational candidate, lifitegrast, for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter (CRL) the company received from the FDA on October 16, 2015.
MicroConstants, a GLP-compliant Contract Research Organization specializing in bioanalytical and pharmacokinetic analysis, has acquired access to a new nanosizing technology that transforms water insoluble compounds into nanoparticles, making formulation preparation and dosing for toxicology studies easier.
A University of Leicester-led study may have uncovered the reason why Beta-blockers are less effective at preventing stroke in older people with high blood pressure, when compared to other drugs for high blood pressure.
ACCESS PHARMACEUTICALS, INC., an emerging biopharmaceutical company, today announced that it had entered into an exclusive license agreement with Norgine B.V., a leading independent European specialty pharmaceutical company, for the commercialization of MuGard in Europe.
In a new trial, Swedish researchers will investigate if a medicine normally used to treat prostate cancer can also be used to treat COVID-19 in patients.
› Verified 6 days ago
Dr. Susan Diane Thompson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Dept. Of Veterans Affairs, Vamc, 50 Irving Street, Washington Dc, DC 20422 Phone: 202-745-8000 Fax: 202-745-8694 | |
Obiora Matthias Ogbuawa, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1615 Rhode Island Avenue Ne, Washington Dc, DC 20018 Phone: 202-636-3781 Fax: 202-832-0575 |